GSTU27 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
GSTU27 antibody; At3g43800 antibody; T28A8.90 antibody; Glutathione S-transferase U27 antibody; AtGSTU27 antibody; EC 2.5.1.18 antibody; GST class-tau member 27 antibody
Target Names
GSTU27
Uniprot No.

Target Background

Function
GSTU27 Antibody may play a role in the conjugation of reduced glutathione to a wide variety of exogenous and endogenous hydrophobic electrophiles. This conjugation process contributes to detoxification against certain herbicides.
Database Links

KEGG: ath:AT3G43800

STRING: 3702.AT3G43800.1

UniGene: At.20539

Protein Families
GST superfamily, Tau family
Subcellular Location
Cytoplasm, cytosol.

Q&A

What is GSTU27 and how does it function in plant biological systems?

GSTU27 belongs to the plant-specific Tau class of Glutathione S-transferases, enzymes that catalyze the conjugation of reduced glutathione to various hydrophobic electrophiles. This enzyme plays crucial roles in xenobiotic detoxification, oxidative stress responses, and secondary metabolism in plants. The GSTU27 protein follows similar functional patterns to other GST family members like GSTF6, which catalyzes the conjugation of glutathione with indole-3-acetonitrile in Arabidopsis, a critical step in plant defense compound biosynthesis . Unlike mammalian GSTs such as GSTM3, which functions at the testis and brain blood barriers , GSTU27 has evolved specialized roles in plant stress adaptation and defense mechanisms.

In research contexts, GSTU27 is frequently studied for its involvement in herbicide detoxification, environmental stress responses, and plant-pathogen interactions. The enzyme's substrate specificity is determined by its unique binding pocket architecture, which differs from other GST classes and accounts for its distinct substrate preferences in plant systems.

What are the key considerations for selecting an appropriate GSTU27 antibody for research?

When selecting a GSTU27 antibody for research, several critical factors must be evaluated to ensure experimental success:

Antibody Format and Detection System:

  • Consider whether an unconjugated or conjugated antibody is optimal for your application. HRP-conjugated antibodies (similar to the GSTA2 antibody) offer direct detection without secondary antibodies, simplifying western blotting protocols . Fluorophore-conjugated antibodies may be preferable for immunofluorescence or flow cytometry applications.

Host Species and Clonality:

  • Rabbit polyclonal antibodies provide broader epitope recognition, similar to the GSTM3 antibody approach , while monoclonal antibodies offer higher specificity for single epitopes. The host species should be selected to avoid cross-reactivity in multi-labeling experiments.

Epitope Selection and Specificity:

  • Antibodies raised against unique regions of GSTU27 minimize cross-reactivity with other GST family members. Consider whether the antibody targets full-length protein or specific domains. Antibodies recognizing epitopes within amino acids 150 to C-terminus (similar to the GSTM3 antibody approach) may provide specific recognition .

Validation Data Requirements:

  • Examine available validation data including western blot images showing the expected molecular weight (typically 25-28 kDa for GST proteins), positive control tissues, and specificity tests. Comprehensive validation across multiple applications is ideal.

Application Compatibility:

  • Verify the antibody has been validated for your specific application (Western blot, IHC-P, etc.) with your experimental system. Some antibodies perform well in certain applications but poorly in others.

These considerations ensure selection of an appropriate GSTU27 antibody that will yield reliable and reproducible results across your experimental workflow.

How should Western blotting protocols be optimized for GSTU27 detection?

Western blotting for GSTU27 requires careful optimization to achieve specific detection with minimal background. Based on established protocols for GST family antibodies, the following methodological approach is recommended:

Sample Preparation:

  • Extract proteins using buffers containing protease inhibitors to prevent degradation

  • Determine optimal protein concentration (typically 20-50 μg total protein per lane)

  • Use reducing conditions with SDS-PAGE (10-12% gels recommended for GST proteins)

Transfer and Blocking:

  • Transfer to PVDF or nitrocellulose membranes at 100V for 60-90 minutes (wet transfer) or 25V for 7-10 minutes (semi-dry)

  • Block with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

Antibody Incubation Parameters:

  • Primary antibody dilution: Start with 1:500-1:1000 for polyclonal antibodies (similar to the 1:500 dilution used for GSTM3 antibody)

  • For HRP-conjugated antibodies (like the GSTA2 antibody), direct detection without secondary antibody may be possible

  • Incubation time: Overnight at 4°C for maximum sensitivity or 2 hours at room temperature

  • Secondary antibody: Species-appropriate HRP-conjugated secondary antibody at 1:2000-1:5000 dilution

Detection and Quantification:

  • Use ECL substrate for detection (enhanced sensitivity formulations for low abundance targets)

  • Expected band size for GSTU27: approximately 25-28 kDa (based on typical GST protein sizes)

  • For quantification, include a standard curve of recombinant protein if available

  • Use consistent exposure times across experimental replicates

Essential Controls:

  • Positive control: Tissue/cell lysate known to express GSTU27

  • Negative control: Lysate from tissue/cells not expressing the target or GSTU27 knockout material

  • Loading control: Housekeeping protein antibody (β-actin, GAPDH)

This protocol should be further optimized for your specific experimental system, antibody lot, and GSTU27 expression levels in your samples.

What approaches ensure proper validation of GSTU27 antibody specificity?

Comprehensive validation of GSTU27 antibody specificity is essential for generating reliable research data. A multi-layered approach employing complementary methods is recommended:

Western Blot Validation Strategy:

  • Compare wild-type samples with GSTU27 knockout/knockdown samples

  • Examine multiple tissue types with varying GSTU27 expression levels

  • Perform peptide competition assays by pre-incubating the antibody with excess immunizing peptide

  • Check for expected molecular weight (similar to the predicted 27 kDa for GSTM3)

  • Test for cross-reactivity with recombinant proteins of related GST family members

Mass Spectrometry Confirmation:

  • Perform immunoprecipitation with the GSTU27 antibody

  • Analyze pulled-down proteins by mass spectrometry

  • Confirm GSTU27 is the predominant protein identified (similar to the MALDI-TOF MS approach used for identifying GSTF proteins)

  • Look for sequence coverage higher than 15% and more than five peptide matches for confident identification

Immunohistochemistry Validation:

  • Compare staining patterns with known expression profiles

  • Include positive and negative control tissues

  • Perform staining with secondary antibody only to assess background

  • Test multiple fixation and antigen retrieval methods to optimize signal-to-noise ratio

Orthogonal Validation Methods:

  • Correlate protein detection with mRNA expression levels

  • Use multiple antibodies targeting different epitopes of GSTU27 if available

  • Compare results across different detection methods (e.g., Western blot vs. ELISA)

This systematic validation approach ensures the antibody specifically recognizes GSTU27 with minimal cross-reactivity, providing a solid foundation for subsequent experimental work.

How should immunoprecipitation protocols be adapted for GSTU27 studies?

Immunoprecipitation (IP) of GSTU27 requires specific methodological considerations to ensure successful isolation of the protein and its complexes:

Lysis Buffer Optimization:

  • Use non-denaturing lysis buffers to preserve protein-protein interactions

  • Include protease and phosphatase inhibitors to prevent degradation

  • Typical composition: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40 or Triton X-100, 1 mM EDTA

  • Gentle homogenization to preserve protein complexes

Antibody Selection Criteria:

  • Choose high-affinity antibodies validated for IP applications

  • Consider using multiple antibodies targeting different epitopes to confirm results

  • Test antibody binding capacity in pilot experiments

IP Protocol Refinements:

  • Pre-clear lysates with Protein A/G beads to reduce non-specific binding

  • Optimize antibody-to-lysate ratio (typically 2-5 μg antibody per mg protein)

  • Incubate antibody with lysate overnight at 4°C with gentle rotation

  • Use appropriate beads based on antibody host species (Protein A for rabbit, Protein G for mouse)

  • Include extensive washing steps with decreasing salt concentrations

Controls and Validation:

  • Include IgG isotype control to identify non-specific binding

  • Verify IP efficiency by western blotting input, unbound, and eluted fractions

  • Confirm identity of precipitated proteins via mass spectrometry

  • For co-IP studies, validate interactions with reciprocal IP experiments

Downstream Applications:

  • For protein interaction studies, consider crosslinking before lysis

  • For enzymatic activity assays, use gentler elution conditions to preserve function

  • For identifying post-translational modifications, include appropriate inhibitors

  • For substrate identification, consider activity-based protein profiling approaches

This methodological framework can be adapted to identify GSTU27 interacting proteins, associated substrates, or post-translational modifications, providing valuable insights into the protein's function in plant biological systems.

How should researchers interpret GSTU27 expression patterns across different plant tissues and stress conditions?

Interpreting GSTU27 expression patterns requires careful consideration of biological context and experimental variables:

Tissue-Specific Expression Analysis:

  • Establish baseline expression in different tissues under normal conditions

  • Consider developmental stage-specific expression patterns

  • Compare with expression patterns of other GST family members

  • Relate tissue expression to known biological functions (e.g., detoxification at specific barriers)

Stress-Induced Expression Dynamics:

  • Examine both the timing and magnitude of GSTU27 induction under stress

  • Compare different stressors to identify specific vs. general stress responses

  • Consider both transcriptional and post-transcriptional regulation

  • Look for coordinated expression with related enzymes, similar to how GSTF6, GGT1, GGT2, and PCS1 showed coordinated upregulation during camalexin biosynthesis

Quantitative Analysis Framework:

  • Normalize GSTU27 expression to appropriate reference genes/proteins

  • Apply statistical analysis to determine significance of observed variations

  • Consider fold-changes relative to control conditions (typically ≥2-fold is biologically relevant)

  • Analyze across multiple biological replicates (minimum n=3)

Confounding Factors to Consider:

  • Post-translational modifications affecting antibody recognition

  • Presence of splice variants or isoforms in different tissues

  • Cross-reactivity with related GST family members

  • Different extraction efficiencies across diverse tissue types

Interpretation Integration Points:

  • Correlate protein expression with enzyme activity assays when possible

  • Connect expression changes to physiological responses

  • Consider evolutionary context in cross-species comparisons

  • Integrate with transcriptomic data for comprehensive pathway analysis

By systematically analyzing GSTU27 expression patterns within this framework, researchers can derive meaningful biological insights rather than simply documenting changes in protein levels.

What statistical approaches are recommended for analyzing GSTU27 quantification data?

Experimental Design Considerations:

  • Power analysis to determine required sample size (typically minimum n=3-5 biological replicates)

  • Include technical replicates (3 per biological sample) to assess measurement variability

  • Design appropriate controls for each experimental condition

  • Consider factorial designs for multi-variable experiments (e.g., tissue type × stress condition)

Data Preprocessing:

  • Normalize to appropriate reference (loading controls, total protein)

  • Log-transform data if not normally distributed

  • Remove outliers only after careful statistical justification

  • Account for batch effects if experiments were performed across multiple days

Statistical Tests Selection:

  • For two-group comparisons: t-test (paired or unpaired) or non-parametric equivalent (Mann-Whitney)

  • For multi-group comparisons: ANOVA followed by appropriate post-hoc tests (Tukey, Dunnett)

  • For time-course experiments: repeated measures ANOVA or mixed models

  • For correlation analysis: Pearson's or Spearman's correlation coefficients

Advanced Statistical Approaches:

  • Multiple regression for analyzing relationships with multiple variables

  • Principal component analysis for identifying patterns in complex datasets

  • Hierarchical clustering for grouping samples with similar expression profiles

  • Machine learning for predictive modeling of GSTU27 responses

Reporting Standards:

  • Include measures of central tendency (mean/median) and dispersion (SD/SEM)

  • Report exact p-values rather than significance thresholds

  • Include confidence intervals where appropriate

  • Clearly describe all statistical methods in materials and methods section

Sample Statistical Workflow for GSTU27 Analysis:

Analysis StepMethodOutputInterpretation
NormalizationRatio to loading controlNormalized valuesCorrects for loading differences
Distribution checkShapiro-Wilk testp-valueDetermines if parametric tests are appropriate
Group comparisonANOVAF-statistic, p-valueIdentifies significant differences across conditions
Post-hoc analysisTukey's HSDAdjusted p-valuesIdentifies which specific groups differ
Effect size calculationCohen's dEffect size valueQuantifies magnitude of differences

How can GSTU27 antibodies be employed in plant detoxification pathway studies?

GSTU27 antibodies serve as powerful tools for elucidating detoxification mechanisms in plants through several advanced research approaches:

Mechanistic Studies of Glutathione Conjugation:

  • Immunoprecipitate GSTU27 to identify associated proteins and substrates

  • Use antibodies to track GSTU27 involvement in xenobiotic metabolism

  • Investigate enzyme-substrate interactions through activity-based protein profiling

  • Similar to how GSTF6 was studied in glutathione-indole-3-acetonitrile formation in Arabidopsis

Detoxification Pathway Mapping:

  • Track GSTU27 involvement throughout complete detoxification processes

  • Identify pathway intermediates similar to how GSH(IAN), (IAN)CysGly, and γGluCys(IAN) were identified as intermediates in camalexin biosynthesis

  • Establish GSTU27's position relative to other detoxification enzymes

  • Investigate relationships with γ-glutamyl transpeptidases (GGTs) and other pathway components

Herbicide Resistance Mechanisms:

  • Compare GSTU27 expression between herbicide-resistant and susceptible plant varieties

  • Analyze correlation between GSTU27 levels and herbicide metabolism rates

  • Characterize herbicide-glutathione conjugates formed through GSTU27 activity

  • Develop antibody-based screening methods for predicting herbicide resistance

Substrate Specificity Characterization:

  • Use purified GSTU27 (isolated via immunoprecipitation) for in vitro enzyme assays

  • Determine kinetic parameters for various potential substrates

  • Compare substrate preferences across GST family members

  • Analyze how structural features influence substrate recognition

Advanced Experimental Workflow Example:

  • Expose plant tissues to xenobiotic compounds (herbicides, environmental toxins)

  • Monitor GSTU27 expression using western blotting with validated antibodies

  • Immunoprecipitate GSTU27 from treated tissues

  • Analyze co-precipitated metabolites via LC-MS/MS

  • Perform in vitro assays with purified GSTU27 and candidate substrates

  • Use GSTU27 knockout/overexpression lines to confirm in vivo function

  • Characterize glutathione-conjugated metabolites and downstream catabolites

This integrated approach provides a comprehensive understanding of GSTU27's specific role in plant detoxification processes and its contribution to stress adaptation.

What approaches enable integration of GSTU27 antibody data with multi-omics studies?

Integration of GSTU27 antibody-based research with multi-omics technologies enables systems-level understanding of its biological functions:

Proteomics Integration Strategies:

  • Antibody-based enrichment of GSTU27 interactome followed by mass spectrometry

  • Quantitative changes in GSTU27 complex formation under various stresses

  • Identification of post-translational modifications using immunoprecipitation and MS/MS

  • Spatial proteomics to map GSTU27 subcellular localization dynamics

  • Similar to the proteomics approaches used to identify GSTFs and related proteins

Transcriptomics Correlation Approaches:

  • Parallel analysis of GSTU27 protein (using antibodies) and mRNA levels

  • Correlation with expression patterns of other detoxification enzymes

  • Analysis of transcription factors regulating GSTU27 expression

  • RNA-seq of GSTU27 knockout lines to identify downstream effects

Metabolomics Integration:

  • Antibody-based pull-down of GSTU27-substrate complexes for metabolite identification

  • Comparative metabolomics between wild-type and GSTU27 knockout lines

  • Tracking of glutathione conjugates and their metabolites in various stress conditions

  • Identification of detoxification intermediates similar to the GSH-conjugates found in camalexin biosynthesis

Multi-omics Data Integration Framework:

Omics LevelTechniqueGSTU27 Antibody ApplicationOutput
ProteomicsIP-MSGSTU27 pulldownInteractome mapping
PTM-omicsIP + MS/MSGSTU27 enrichmentModification landscape
MetabolomicsActivity-based profilingGSTU27 substrate captureSubstrate identification
PhenomicsHigh-content screeningGSTU27 immunofluorescenceSubcellular dynamics
InteractomicsCo-IPProtein complex isolationPathway reconstruction

Data Analysis and Integration Approaches:

  • Network analysis to position GSTU27 in stress response pathways

  • Correlation analysis between GSTU27 levels and metabolic profiles

  • Machine learning to identify patterns across multi-omics datasets

  • Pathway enrichment analysis to identify biological processes affected by GSTU27

This multi-omics integration approach generates comprehensive insights into GSTU27's functional role within the broader cellular and physiological context of plant stress responses.

What are the most common technical challenges when working with GSTU27 antibodies and their solutions?

Researchers working with GSTU27 antibodies may encounter several technical challenges that require systematic troubleshooting:

Cross-Reactivity with Related GST Family Members:
Challenge: GST family proteins share sequence homology, potentially leading to non-specific signals.
Solution:

  • Validate antibody specificity against recombinant GST family members

  • Use GSTU27 knockout samples as negative controls

  • Perform peptide competition assays to confirm specific binding

  • Select antibodies raised against unique regions of GSTU27

  • Compare results with orthogonal detection methods

Inconsistent Western Blot Results:
Challenge: Variable detection of GSTU27 across experiments.
Solution:

  • Standardize protein extraction methods (consistent buffers, inhibitors)

  • Prepare antibody aliquots to reduce freeze-thaw cycles

  • Maintain consistent incubation times and temperatures

  • Use internal standards across experiments

  • Document lot numbers and validate each new antibody lot

High Background in Immunohistochemistry:
Challenge: Non-specific staining obscuring specific GSTU27 signals.
Solution:

  • Optimize blocking conditions (try different blockers: BSA, normal serum)

  • Extend washing steps (more washes, longer durations)

  • Titrate antibody to determine optimal concentration

  • Consider antigen retrieval optimization

  • Use more specific detection systems

  • Similar to the approach used for GSTM3 staining in human tissues

Methodological Table for Troubleshooting GSTU27 Antibody Issues:

IssueDiagnostic ApproachCorrective ActionValidation Step
No signalTest antibody with positive controlAdjust concentration; check secondary antibodyConfirm with alternative detection method
Multiple bandsAnalyze MW of unexpected bandsIncrease washing stringency; use peptide competitionCompare with mRNA expression pattern
Variable resultsCheck consistency across sample prepStandardize protocols; use internal controlsRun inter-assay controls
High backgroundPerform secondary-only controlOptimize blocking and washingTitrate antibody to find optimal S/N ratio
Degraded signalCheck sample integrityAdd protease inhibitors; reduce processing timeRun freshly prepared samples

By implementing these systematic troubleshooting approaches, researchers can overcome technical challenges and obtain reliable, reproducible results with GSTU27 antibodies.

What are the optimal storage and handling protocols for maintaining GSTU27 antibody activity?

Proper storage and handling of GSTU27 antibodies is critical for maintaining their activity and ensuring reproducible experimental results:

Storage Temperature Guidelines:

  • Unconjugated antibodies: Store at -20°C for long-term storage

  • HRP-conjugated antibodies: Store at 4°C to prevent freeze-thaw damage to the enzyme (similar to the GSTA2 HRP-conjugated antibody storage recommendations)

  • Fluorophore-conjugated antibodies: Store at -20°C in dark conditions to prevent photobleaching

  • Working dilutions: Store at 4°C for short-term use (1-2 weeks maximum)

Strategic Aliquoting Approach:

  • Divide stock antibody into single-use aliquots upon receipt

  • Use small volumes (10-20 μL) to minimize freeze-thaw cycles

  • Label aliquots with antibody details, concentration, and date

  • Keep one aliquot for antibody validation and QC purposes

Buffer Composition Considerations:

  • Store in manufacturer's recommended buffer

  • Typical storage buffers contain:

    • PBS or TBS base

    • 0.02-0.05% sodium azide as preservative

    • 50% glycerol to prevent freeze-thaw damage

    • Carrier proteins (BSA or gelatin) at 1-5 mg/mL

Proper Handling Procedures:

  • Minimize freeze-thaw cycles (ideally ≤5 total)

  • Allow antibodies to thaw completely at 4°C before handling

  • Centrifuge briefly before opening tubes to collect liquid

  • Use clean pipette tips to prevent contamination

  • Return to storage promptly after use

Stability Monitoring Recommendations:

Antibody TypeOptimal Storage ConditionExpected Stability PeriodSigns of Deterioration
Unconjugated−20°C in glycerol buffer2-5 yearsDecreased signal intensity
HRP-conjugated4°C6-12 monthsHigher background, lower signal
Fluorophore-conjugated−20°C, protected from light6-18 monthsDecreased fluorescence intensity
Diluted working stock4°C1-2 weeksIncreased background, precipitates

Following these storage and handling recommendations will help ensure consistent performance of GSTU27 antibodies throughout your research project, reducing variability and improving experimental reproducibility.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.